Compugen Ltd (CGEN)

Jan 06, 2026

Is Compugen Ltd. stock a bargain at current levels2026 world cup usa national team third place match top scorers counter attacking knockout prediction preview - Улправда

Jan 06, 2026

Jan 06, 2026

Compugen rises on royalty deal with AstraZeneca - MSN

Jan 06, 2026

Dec 23, 2025

Operating cash flow per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets

Dec 23, 2025

Dec 20, 2025

Why Compugen Ltd. stock could benefit from AI revolutionMarket Sentiment Summary & Consistent Profit Trading Strategies - Улправда

Dec 20, 2025

Dec 20, 2025

Will Compugen Ltd. stock benefit from sector rotationWeekly Profit Summary & Daily Growth Stock Tips - Улправда

Dec 20, 2025

Dec 19, 2025

Is Compugen Ltd. stock a defensive play in 2025Portfolio Gains Summary & Real-Time Volume Analysis Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Can Compugen Ltd. stock deliver strong Q4 earningsJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда

Dec 19, 2025

Dec 19, 2025

Bull Run: Why Compugen Ltd. stock could benefit from AI revolutionJuly 2025 Reactions & Risk Controlled Stock Pick Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca - The Globe and Mail

Dec 18, 2025

Dec 17, 2025

Compugen shares jump after $65 million royalty monetization deal with AstraZeneca - MSN

Dec 17, 2025

Dec 17, 2025

Compugen (CGEN) Rises on Royalty Deal with AstraZeneca - GuruFocus

Dec 17, 2025

Dec 17, 2025

Compugen restructures AstraZeneca deal to boost cash coffers - גלובס

Dec 17, 2025

Dec 17, 2025

Compugen stock soars on $65 million AstraZeneca royalty deal By Investing.com - Investing.com Nigeria

Dec 17, 2025

Dec 17, 2025

Compugen stock soars on $65 million AstraZeneca royalty deal - Investing.com

Dec 17, 2025

Dec 17, 2025

Compugen Monetizes Portion of Cancer Treatment Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com

Dec 17, 2025

Dec 17, 2025

Compugen rises on royalty deal with AstraZeneca (CGEN:NASDAQ) - Seeking Alpha

Dec 17, 2025

Dec 17, 2025

Compugen monetizes portion of cancer drug royalties to AstraZeneca By Investing.com - Investing.com South Africa

Dec 17, 2025

Dec 17, 2025

Compugen monetizes portion of cancer drug royalties to AstraZeneca - Investing.com

Dec 17, 2025

Dec 17, 2025

Compugen monetizes portion of rilvegostomig future royalties to AstraZeneca for up to $90 million - marketscreener.com

Dec 17, 2025

Dec 17, 2025

Compugen Ltd. and Medimmune Limited Enter into Amendment Number 4 to the License Agreement - marketscreener.com

Dec 17, 2025

Dec 17, 2025

Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million - TradingView — Track All Markets

Dec 17, 2025

Dec 17, 2025

[6-K] COMPUGEN LTD Current Report (Foreign Issuer) | CGEN SEC FilingForm 6-K - Stock Titan

Dec 17, 2025

Dec 17, 2025

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com

Dec 17, 2025

Dec 17, 2025

Cancer immunotherapy royalty deal brings biotech up to $90M in funding - Stock Titan

Dec 17, 2025

Dec 16, 2025

Compugen secures $90 million in a strategic royalty monetization deal with AstraZeneca - MSN

Dec 16, 2025

Dec 11, 2025

Revenue per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets

Dec 11, 2025

Dec 05, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Dec 05, 2025

Dec 04, 2025

Compugen Presents Promising COM701 Analysis at ESMO 2025 - MSN

Dec 04, 2025

Dec 02, 2025

Compugen’s Former Head Reflects on Computational Discovery, Strategic Collaborations And AI - Citeline News & Insights

Dec 02, 2025

Nov 30, 2025

Compugen (NASDAQ:CGEN) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat

Nov 30, 2025

Nov 27, 2025

Compugen Ltd (CGEN) Stock Price & 30 Year Financial Data - GuruFocus

Nov 27, 2025

Nov 22, 2025

Compugen (NASDAQ:CGEN) versus PepGen (NASDAQ:PEPG) Critical Review - Defense World

Nov 22, 2025

Nov 20, 2025

Can Compugen Ltd. stock beat analyst upgrades2025 Risk Factors & AI Based Buy and Sell Signals - newser.com

Nov 20, 2025

Nov 19, 2025

What indicators show strength in Compugen Ltd.Layoff News & Fast Momentum Entry Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Is Compugen Ltd. stock oversold or undervaluedJuly 2025 Trade Ideas & Community Verified Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

What high frequency data says about Compugen Ltd.July 2025 Action & High Accuracy Trade Signal Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Real time social sentiment graph for Compugen Ltd.Portfolio Risk Report & Reliable Entry Point Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How interest rate cuts could boost Compugen Ltd. stockQuarterly Market Summary & Verified Swing Trading Watchlist - newser.com

Nov 19, 2025

Nov 19, 2025

Is now a turning point for Compugen Ltd.Stock Surge & AI Driven Price Predictions - newser.com

Nov 19, 2025